Following a challenge brought by Novo Nordisk Inc., BBB National Programs’ National Advertising Division recommended Willow ...

Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar ...

Norwegian patients and researchers at Akershus University Hospital and Oslo University Hospital have taken part in two large ...

Ozempic, a once-weekly injectable approved by the US Food and Drug Administration in 2017 for type 2 diabetes, has become a ...

Danish pharmaceutical company, Novo Nordisk, is set to introduce its diabetes drug, Ozempic, in India this December ...

India has the second-highest number of people with type 2 diabetes after China and rising obesity rates, making it a critical battleground for drugmakers ...

Hims & Hers Health has sold off ~40% GLP-1 turbulence, but the core growth story remains intact. Read why HIMS stock is a ...

A new oral GLP-1 receptor agonist, orforglipron, is revolutionizing weight management by offering a needle-free alternative ...

Some online clinics claim convenience and confidentiality as benefits, but charge a premium for being the middleman for a ...

Does Weight Loss Medication Work? Key takeaways Weight loss medications work for many people. They can help those with ...